Why Creams are
Used to Treat
Skin Cancer and
What Does It Help
With?
Creams are an increasingly popular method for
treating certain types of skin cancer, particularly in
cases where the cancer is localized to the upper
layers of the skin. This treatment approach is
especially common for non-melanoma skin cancers
such as basal cell carcinoma, squamous cell
carcinoma in situ (Bowen’s disease), and
pre-cancerous conditions like actinic keratosis. The
appeal of using creams lies in their non-invasive
nature, ability to be applied at home, and their
capacity to specifically target abnormal cells while
preserving surrounding healthy tissue.
Two of the most commonly used topical treatments
are imiquimod and 5-fluorouracil (5-FU).
Imiquimod works by stimulating the body’s immune
system to recognize and destroy cancerous cells.
On the other hand, 5-FU is a type of chemotherapy
agent that directly interferes with the DNA synthesis
of rapidly dividing cancer cells, effectively killing
them over time.
Topical treatments are often recommended for
patients with superficial or early-stage skin cancers,
especially in cosmetically sensitive areas such as
the face, scalp, neck, or chest. They are a great
alternative to surgery when scarring is a concern or
when the lesion is too large or numerous for surgical
intervention. Moreover, creams can reduce recovery
time and offer a convenient, less disruptive
treatment process.
While not suitable for all forms of skin cancer,
especially those that have spread beyond the
surface, creams offer a valuable, patient-friendly
option for skin cancer management. Their
effectiveness, when used correctly and under
medical supervision, makes them an important part
of dermatologic oncology.